Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/10/2009 | US7488801 Interferon-alpha polypeptides and conjugates |
02/10/2009 | US7488796 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins |
02/10/2009 | US7488716 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
02/10/2009 | US7488715 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
02/10/2009 | US7488714 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
02/10/2009 | US7488591 Controlling formation of acidic sugar chain associated with heterologously expressed glycoproteins in pichia; preparing less antigenic polypeptides; pharmacology; drug design; gene participating in addition of mannose phosphate to a sugar chain in a core-like sugar chain of a glycoprotein is controlled |
02/10/2009 | US7488590 Fusion of Fc domains with biologically active peptides; selecting peptide that modulates the activity of AGP-3, preparing a gene construct; expressing the pharmacologically active compound in which an Fc domain is covalently linked to peptide |
02/10/2009 | US7488589 Interferon-alpha polypeptides and conjugates |
02/10/2009 | US7488588 Compounds related to or derived from GFR α4 and their use |
02/10/2009 | US7488586 PRO4409 polypeptides |
02/10/2009 | US7488583 Fragment complementation assays for G-protein-coupled receptors and their signaling pathways |
02/10/2009 | US7488488 Polypeptide, polynucleotide, vector, transformant, antibody, vaccine, and receptor binding assay; miticide vaccines or prophylactic and preventitive vaccines for piroplasmosis, Q fever, or viral encephalitis |
02/10/2009 | US7488475 Antibody therapy of tumors |
02/10/2009 | US7488473 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
02/10/2009 | CA2441187C Acetyllysine-recognizing monoclonal antibody and process for producing the same |
02/10/2009 | CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
02/10/2009 | CA2329776C Antibody against lar phosphatase subunit |
02/10/2009 | CA2210951C Modified thermostable dna polymerase |
02/10/2009 | CA2165197C Recombinant stratum corneum chymotryptic enzyme (scce) |
02/05/2009 | WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein |
02/05/2009 | WO2009016326A2 Adeno-associated viral vectors for the expression of dysferlin |
02/05/2009 | WO2008144485A3 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity |
02/05/2009 | US20090036576 Cyanophycin Production From Nitrogen-Containing Chemicals Obtained From Biomass |
02/05/2009 | US20090036398 Human G-Protein Coupled Receptor (HETGQ23) |
02/05/2009 | US20090036382 TGF-Beta Modulators and Use Thereof |
02/05/2009 | US20090036377 Bacillus thuringiensis; conferring pesticidal activity to bacteria, plants, plant cells, tissues and seeds; controlling beetles; vectors, host cells |
02/05/2009 | US20090036370 Leukocyte Adhesion Inhibitor-1 (LAI-1) |
02/05/2009 | US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
02/05/2009 | US20090036358 Methods of preparing pharmaceutical compositions for treatment of factor Vlll associated disorders and methods of use |
02/05/2009 | US20090035836 Modulating ph-sensitive binding using non-natural amino acids |
02/05/2009 | US20090035822 Fusion Proteins |
02/05/2009 | US20090035821 Expression of Proteins in E.Coli |
02/05/2009 | US20090035820 Nucleic acid constructs, expression vectors, and recombinant host cells comprising such nucleotide sequences; detergents; leather; food; dairyproducts; drugs; cheeses; tanning; cost efficiency; industrial scale |
02/05/2009 | US20090035819 CA125 gene and its use for diagnostic and therapeutic interventions |
02/05/2009 | US20090035818 Novel Polypeptide, Polynucleotide Encoding the Polypeptide and Use the Polypeptide and Polynucleotide |
02/05/2009 | US20090035817 Method for Preparing Transformants Expressing Benzaldehyde Dehydrogenase and Preparation of 2,6-Naphthalene Dicarboxylic Acid Using the Transformants |
02/05/2009 | US20090035816 Process for the preparation of a polypeptide |
02/05/2009 | US20090035815 Synthetic Gene for Enhanced Expression in E. Coli |
02/05/2009 | US20090035814 Method for producing circular or multimeric protein species in vivo or in vitro and related methods |
02/05/2009 | US20090035813 Oligosaccharide mixture |
02/05/2009 | US20090035805 C3A Serum-Free Clonal Cell Line and Methods of Use |
02/05/2009 | US20090035799 Novel trypsin family serine proteases |
02/05/2009 | US20090035798 Methods for Reducing the Immunogenicity of Cytokines and Removal of Cell Surface Markers |
02/05/2009 | US20090035783 Fluorescent proteins and uses thereof |
02/05/2009 | US20090035771 gene expression; probes, primers, antibodies |
02/05/2009 | US20090035756 Methods for arbitrary peptide synthesis |
02/05/2009 | US20090035328 fHbp- AND LPXL1-BASED VESICLE VACCINES FOR BROAD SPECTRUM PROTECTION AGAINST DISEASES CAUSED BY NEISSERIA MENINGITIDIS |
02/05/2009 | US20090035327 Antibody Gene Transfer and Recombinant AAV Therefor |
02/05/2009 | US20090035322 Human Antibodies to Human CD20 and Method of Using Thereof |
02/05/2009 | US20090035319 Antibodies Against C3a Receptor |
02/05/2009 | US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC) |
02/05/2009 | US20090035312 Tumor angiogenesis associated genes and a method for their identification |
02/05/2009 | US20090035307 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
02/05/2009 | US20090035291 Therapeutic use of adpase enhanced apyrases |
02/05/2009 | US20090035287 Atrial natriuretic peptide (anp) splice variants and methods of using same |
02/05/2009 | US20090035261 for treating degenerative cartilaginous disorders and other inflammatory diseases; inhibiting the proliferation of T-lymphocytes; modulating infiltration of inflammatory cells into a tissue of a mammal |
02/05/2009 | US20090035255 Conjugate for targeting of drug |
02/05/2009 | CA2697127A1 Adeno-associated viral vectors for the expression of dysferlin |
02/05/2009 | CA2694990A1 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
02/04/2009 | EP2020417A1 Prostasin partial peptide and anti-prostasin antibody |
02/04/2009 | EP2019864A2 Preparation and uses of gene sequences encoding chimerical glycosyltransferases with optimized glycosylation activity |
02/04/2009 | EP2019860A2 Protein production using eukaryotic cell lines |
02/04/2009 | EP1476750B1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of systemic lupus erythematosus (sle) |
02/04/2009 | EP1302544B1 Medium additives and media for culturing animal cells |
02/04/2009 | EP1232269B1 Method for purifying recombinant hexose oxidase |
02/04/2009 | CN101360831A Recombinant N-glycosylated proteins from procaryotic cells |
02/04/2009 | CN101358225A Method for preparing high sialic acid content immune globulin antibody and application |
02/04/2009 | CN100457914C Recombinant protein production in human cell using sequences encoding adenovirus E1 protein |
02/04/2009 | CN100457909C Methods for large scale protein production in prokaryotes |
02/04/2009 | CN100457908C Recombinant stratum corneum chymotryptic enzyme (SCCE) |
02/04/2009 | CN100457907C Recombinant helicobacter pylori outer-membrane protein 15 |
02/04/2009 | CN100457901C Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
02/04/2009 | CN100457781C Antibodies against cancer |
02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
02/04/2009 | CN100457189C Fusions of cytokines and tumor targeting proteins |
02/04/2009 | CN100456920C Corn plants with improved quality traits of seeds |
02/03/2009 | US7485714 Induction cell differentiation with dimethyl sulfoxide; quantitative analysis |
02/03/2009 | US7485713 Polypeptides comprising growth hormone receptor extracellular domain and glycosylphosphatidylinositol |
02/03/2009 | US7485712 A DNA sequence encoding a novel neuronal protein kinase (NPK) which phosphorylates tau proteins; for the treatment of Alzheimer's disease and cancer, diagnostic kits and in vitro diagnostic methods for the diseases |
02/03/2009 | US7485702 Homogeneous preparations of IL-28A cysteine mutants |
02/03/2009 | US7485701 Homogeneous preparations of IL-28 and IL-29 |
02/03/2009 | US7485700 Interferon-like protein ZCYTO21 |
02/03/2009 | US7485697 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
02/03/2009 | US7485621 Tumor tag and the use thereof |
02/03/2009 | US7485618 FGF-5 supported and binding peptides |
02/03/2009 | US7485458 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
02/03/2009 | US7485456 Drug screening for a molecule capable of binding to NIK (nuclear factor kappa B inducing kinase); DNA sequence encoding a protein capable of binding to a tumor necrosis factor receptor-associated factor (TRAF) molecule, TRAF-binding proteins, isoforms, analogs, fragments and derivatives; gene expression |
02/03/2009 | US7485454 Microreactor |
02/03/2009 | US7485448 Serum-free medium for producing retroviruses |
02/03/2009 | US7485441 Chimeric DNA-binding proteins |
02/03/2009 | US7485440 Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2 |
02/03/2009 | US7485439 Nucleic acids encoding plasminogen fragments and methods of use |
02/03/2009 | US7485432 Selective modulation of TLR-mediated biological activity |
02/03/2009 | US7485429 Genetically engineered polypeptide comprising extracellular domain of integrin subunit alpha 11; marker or target of all types of cells; drugs, vaccines |
02/03/2009 | US7485427 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
02/03/2009 | US7485414 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
02/03/2009 | US7485313 Administering an isolated and purified recombinant Chlamydia trachomatis pgp3 protein having its native amino acid conformation to elicit an immune response to a recombinant Chlamydia trachomatis pgp3 protein |
02/03/2009 | US7485308 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor |
02/03/2009 | US7485306 Lutzomyia longipalpis polypeptides and methods of use |
02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |